GlassScriptPhysician profile
Amy L Davis
NPI 1922044155
$6,379.97
in general payments reported to CMS, 2019-2025
32 companies · $75.12 in 2025
The $75.12 reported for 2025 was less than what a typical Adult Health (Nurse Practitioner) provider received nationally (typical 2025 total: $182).
See the full distribution for Adult Health (Nurse Practitioner)
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2021: $2,292 · 2022: $2,159 · 2023: $1,834 · 2024: $19.94 · 2025: $75.12.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $1,914 · Education: $15.27.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $1,914.14 |
| Education | $15.27 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Abbvie INC. | $1,344.81 | 2021-2023 | |
| Leo Pharma INC. | $912.82 | 2021-2023 | Adbry |
| Pfizer INC. | $572.85 | 2021-2023 | |
| Sun Pharmaceutical Industries INC. | $551.64 | 2021-2023 | Ilumya, Winlevi, Absorica Ld |
| Incyte Corporation | $351.23 | 2021-2025 | Opzelura |
| Amgen INC. | $309.68 | 2021-2023 | Otezla, Enbrel |
| Ortho Dermatologics, A Division of Bausch Health US, LLC | $279.22 | 2021-2023 | Jublia |
| Janssen Biotech, INC. | $251.39 | 2021-2023 | Tremfya, Simponi, Stelara |
| Lilly USA, LLC | $227.03 | 2021-2023 | Taltz, Olumiant |
| Epi Health, LLC | $210.66 | 2021-2022 | |
| Galderma Laboratories, L.P. | $208.22 | 2021-2025 | Aklief, Nemluvio |
| Regeneron Healthcare Solutions, INC. | $203.55 | 2021-2023 | Dupixent |
| Genzyme Corporation | $193.47 | 2021-2023 | |
| Janssen Scientific Affairs, LLC | $123.79 | 2021 | |
| Ucb, INC. | $86.79 | 2021-2023 | Bimzelx |
Show all 32 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Journey Medical Corporation | $70.86 | 2022 | |
| Novartis Pharmaceuticals Corporation | $62.64 | 2023 | |
| E.R. Squibb & Sons, L.L.C. | $58.77 | 2023-2024 | Sotyktu |
| Vyne Pharmaceuticals INC. | $50.30 | 2021 | |
| Mayne Pharma Commercial LLC | $39.87 | 2021 | |
| Arcutis Biotherapeutics, INC. | $38.21 | 2023 | |
| Allergan, INC. | $35.90 | 2021 | |
| Helsinn Therapeutics (U.S.), INC. | $35.40 | 2022 | |
| Almirall LLC | $24.31 | 2021 | |
| Dermavant Sciences, INC. | $22.56 | 2023 | Vtama |
| Biofrontera INC. | $21.84 | 2023 | Xepi, Bf-Rhodoled, Ameluz |
| Verrica Pharmaceuticals INC. | $18.86 | 2023 | Ycanth |
| Atricure, INC. | $16.77 | 2025 | Synergy Ablation System, Atricure Cryoice Cryoablation System (Cryo2) |
| Boehringer Ingelheim Pharmaceuticals, INC. | $14.58 | 2023 | Spevigo |
| Genentech USA, INC. | $14.35 | 2021 | |
| Organon LLC | $14.24 | 2025 | Vtama |
| Amarin Pharma, INC. | $13.36 | 2022 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Amy Davis listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.